Narcolepsy, biomarkers, and dystonia in light of new evidence.

The International Parkinson and Movement Disorder Society (MDS) gathers thousands of clinicians, researchers, trainees and industry advocates with an interest in current research and approaches to the diagnosis and treatment of movement disorders at its Congress of Parkinson’s Disease and Movement ^Disorders® each year. The purpose is to share ideas, generate interest among all stakeholders, and advance clinical and scientific disciplines.